TruBridge（TBRG）株式概要
TruBridge, Inc.は、米国内外の地域病院、診療所、その他の医療システム向けに医療ソリューションとサービスを提供しています。 詳細
TBRG Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
TruBridge, Inc. 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | US$25.95 |
| 52週高値 | US$26.51 |
| 52週安値 | US$13.88 |
| ベータ | 1.31 |
| 1ヶ月の変化 | 0.89% |
| 3ヶ月変化 | 31.26% |
| 1年変化 | 9.03% |
| 3年間の変化 | 8.76% |
| 5年間の変化 | -20.69% |
| IPOからの変化 | 43.21% |
最新ニュース
ナラティブの更新 • Apr 17
TBRG: Potential IKS Deal And EHR Execution Will Shape Future Re Rating
TruBridge's analyst fair value estimate has shifted from $21.00 to $22.00 as analysts update their models around potential IKS-related opportunities, as well as recent mixed price target moves across the Street. Analyst Commentary Bullish Takeaways Bullish analysts point to the potential IKS transaction as aligned with TruBridge's ongoing review of its business.
新しいナラティブ • Apr 16
AI And Global Delivery Expansion Will Reshape Rural Hospital Solutions Over The Next Decade
Catalysts About TruBridge TruBridge provides revenue cycle, financial health and patient care software and services to hospitals, with a focus on rural and community facilities. What are the underlying business or industry changes driving this perspective?Seeking Alpha • Apr 14
TruBridge: Potential Takeover Target, Upside Fundamentally Supported
Summary TruBridge, Inc. is undergoing an operational turnaround with margin expansion, rising EBITDA, and a shift to high-quality recurring revenue. A potential $600 million takeover by Inventurus Knowledge Systems offers a 36–40% premium to current prices but introduces binary deal risk. TBRG’s recurring revenue remains high at 94%, with stable cash flows and improved profitability despite flat top-line growth. The implied takeover valuation aligns with sector multiples, suggesting the upside is fundamentally supported, not purely speculative. Read the full article on Seeking Alphaナラティブの更新 • Apr 02
TBRG: Revenue Cycle Momentum And EHR Stability Will Support Future Re Rating
Analysts have trimmed their price targets on TruBridge, with the average moving from about $22.67 to $21.00 as they weigh a slightly higher discount rate, modestly different revenue growth and margin assumptions, and a lower future P/E multiple against the company's mix of Revenue Cycle Management growth potential and stable Electronic Health Records operations. Analyst Commentary Recent research updates on TruBridge reflect a mix of optimism around the business model and caution around execution and valuation.Recent updates
ナラティブの更新 • Apr 17
TBRG: Potential IKS Deal And EHR Execution Will Shape Future Re Rating
TruBridge's analyst fair value estimate has shifted from $21.00 to $22.00 as analysts update their models around potential IKS-related opportunities, as well as recent mixed price target moves across the Street. Analyst Commentary Bullish Takeaways Bullish analysts point to the potential IKS transaction as aligned with TruBridge's ongoing review of its business.新しいナラティブ • Apr 16
AI And Global Delivery Expansion Will Reshape Rural Hospital Solutions Over The Next Decade
Catalysts About TruBridge TruBridge provides revenue cycle, financial health and patient care software and services to hospitals, with a focus on rural and community facilities. What are the underlying business or industry changes driving this perspective?Seeking Alpha • Apr 14
TruBridge: Potential Takeover Target, Upside Fundamentally Supported
Summary TruBridge, Inc. is undergoing an operational turnaround with margin expansion, rising EBITDA, and a shift to high-quality recurring revenue. A potential $600 million takeover by Inventurus Knowledge Systems offers a 36–40% premium to current prices but introduces binary deal risk. TBRG’s recurring revenue remains high at 94%, with stable cash flows and improved profitability despite flat top-line growth. The implied takeover valuation aligns with sector multiples, suggesting the upside is fundamentally supported, not purely speculative. Read the full article on Seeking Alphaナラティブの更新 • Apr 02
TBRG: Revenue Cycle Momentum And EHR Stability Will Support Future Re Rating
Analysts have trimmed their price targets on TruBridge, with the average moving from about $22.67 to $21.00 as they weigh a slightly higher discount rate, modestly different revenue growth and margin assumptions, and a lower future P/E multiple against the company's mix of Revenue Cycle Management growth potential and stable Electronic Health Records operations. Analyst Commentary Recent research updates on TruBridge reflect a mix of optimism around the business model and caution around execution and valuation.
新しいナラティブ • Apr 02
AI Expansion And Global Delivery Shift Will Shape A Steady But Capped Future
Catalysts About TruBridge TruBridge provides revenue cycle, financial health and electronic health record solutions to hospitals and healthcare providers, with a particular focus on rural and community facilities. What are the underlying business or industry changes driving this perspective?分析記事 • Feb 12
Returns At TruBridge (NASDAQ:TBRG) Appear To Be Weighed Down
What are the early trends we should look for to identify a stock that could multiply in value over the long term...ナラティブの更新 • Jan 28
TBRG: Revenue Cycle Focus And EHR Stability Will Test Execution Outcomes
Narrative Update The analyst price target for TruBridge has shifted modestly higher to about $22.67 per share, supported by analysts citing the potential of its Revenue Cycle Management focus alongside a steadier Electronic Health Records business, while still calling out execution risk after recent periods of low growth. Analyst Commentary Recent research points to a mixed but constructive view on TruBridge, with analysts focusing on the shift toward Revenue Cycle Management and the steadier Electronic Health Records business when considering valuation and execution risk.ナラティブの更新 • Jan 12
TBRG: Revenue Cycle Realignment And EHR Stability Will Require Steady Execution
Narrative Update The analyst price target for TruBridge now centers around US$23, a modest lift from the prior US$22.60. Analysts point to the potential of the Revenue Cycle Management opportunity alongside a steadier Electronic Health Records business, while still flagging execution risk after recent periods of low growth.ナラティブの更新 • Dec 17
TBRG: Revenue Cycle Shift Will Demand Proven Execution Before Rerating
Analysts raised their price target on TruBridge modestly, citing improving growth prospects from the company’s shift toward revenue cycle management as evidence builds of its long-term earnings potential. Analyst Commentary Bullish Takeaways Bullish analysts view the company’s realignment toward revenue cycle management as a structurally higher growth opportunity compared with its legacy clinical software offerings.ナラティブの更新 • Dec 03
TBRG: Revenue Cycle Pivot Will Require Clear Execution Evidence In 2025
Analysts have nudged their price target on TruBridge slightly higher to approximately $22.60 per share. This reflects increased confidence that the company’s shift toward revenue cycle management can unlock more attractive, evidence-based growth than its legacy clinical software focus.ナラティブの更新 • Nov 19
TBRG: Measured Optimism Will Depend On Evidence Of Execution In 2025
TruBridge's analyst price target has been revised downward from $24.75 to $22.60. Analysts cite recent coverage reflecting cautious optimism about the company's strategic shift toward revenue cycle management, while awaiting clearer evidence of execution before turning more positive.分析記事 • Nov 14
Solid Earnings Reflect TruBridge's (NASDAQ:TBRG) Strength As A Business
Even though TruBridge, Inc.'s ( NASDAQ:TBRG ) recent earnings release was robust, the market didn't seem to notice. We...ナラティブの更新 • Aug 15
AI And India Hub Will Boost Future Healthcare Efficiency
Despite a notable improvement in TruBridge’s net profit margin and a significant decline in its future P/E ratio, the consensus analyst price target has been sharply revised down from $29.25 to $24.75. What's in the News TruBridge lowered its full-year 2025 revenue guidance to $345 million-$350 million from a previous range of $345 million-$360 million; third quarter 2025 revenue is forecasted at $85 million-$87 million.新しいナラティブ • May 31
Digital Automation And AI Will Drive Healthcare Transformation
Increased AI-driven automation, expanded SaaS offerings, and digital transformation are expected to boost operational efficiency, recurring revenue growth, and earnings quality.分析記事 • Feb 14
Would TruBridge (NASDAQ:TBRG) Be Better Off With Less Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...分析記事 • Jan 17
TruBridge, Inc. (NASDAQ:TBRG) Shares Fly 27% But Investors Aren't Buying For Growth
TruBridge, Inc. ( NASDAQ:TBRG ) shares have continued their recent momentum with a 27% gain in the last month alone...分析記事 • Nov 13
TruBridge, Inc.'s (NASDAQ:TBRG) Business And Shares Still Trailing The Industry
TruBridge, Inc.'s ( NASDAQ:TBRG ) price-to-sales (or "P/S") ratio of 0.7x might make it look like a buy right now...分析記事 • Aug 05
Is TruBridge (NASDAQ:TBRG) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...分析記事 • May 25
Is TruBridge, Inc. (NASDAQ:TBRG) Trading At A 38% Discount?
Key Insights The projected fair value for TruBridge is US$16.15 based on 2 Stage Free Cash Flow to Equity Current share...分析記事 • Feb 23
Computer Programs and Systems (NASDAQ:CPSI) Might Be Having Difficulty Using Its Capital Effectively
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...分析記事 • Sep 06
What Does Computer Programs and Systems, Inc.'s (NASDAQ:CPSI) Share Price Indicate?
Computer Programs and Systems, Inc. ( NASDAQ:CPSI ), is not the largest company out there, but it received a lot of...株主還元
| TBRG | US Healthcare Services | US 市場 | |
|---|---|---|---|
| 7D | 0.04% | -1.0% | 1.3% |
| 1Y | 9.0% | -38.9% | 27.7% |
業界別リターン: TBRG過去 1 年間で-38.9 % の収益を上げたUS Healthcare Services業界を上回りました。
リターン対市場: TBRGは、過去 1 年間で27.7 % のリターンを上げたUS市場を下回りました。
価格変動
| TBRG volatility | |
|---|---|
| TBRG Average Weekly Movement | 8.3% |
| Healthcare Services Industry Average Movement | 10.0% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
安定した株価: TBRG 、 US市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。
時間の経過による変動: TBRGの 週次ボラティリティ ( 8% ) は過去 1 年間安定しています。
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 1979 | 3,500 | Chris Fowler | trubridge.com |
トゥルーブリッジ・インクは、米国内外の地域病院、診療所、その他の医療システム向けに医療ソリューションとサービスを提供している。同社はファイナンシャル・ヘルスと患者ケアの2つの分野で事業を展開している。収益サイクル管理（RCM）製品（患者責任見積もり、適格性確認、クレームスクラビングと提出、送金管理、拒否/監査管理、契約管理サービスなど）、RCMサービス（売掛金管理、プライベートペイ・サービス、医療コーディング、収益サイクル・コンサルティング、その他の追加保険および患者請求サービスなど）、コンサルティング、ビジネス・インテリジェンス、人材派遣、管理サービス、クラウド・サービス、バックアップとリカバリ、コラボレーションと接続性、セキュリティ・サービス、システム管理、ヘルプデスク・サービス、エンコーダー・ソリューションなどを提供している。また、TruBridge HERというソフトウェア・ソリューション・プラットフォームも提供している。TruBridge HERは、地域病院の主要機能領域への情報の流れを合理化するために設計された、完全に統合された1つのシステムを使用して、さまざまなソフトウェア・アプリケーションを提供する。さらに、トータル・システム・サポート、全国顧客会議、継続教育、ソフトウェア・リリース、ハードウェア交換、クラウド電子カルテ、フォームおよび消耗品、インスタントPHR、CHBaseからなる急性期医療サポートおよびメンテナンス・サービスも提供している。さらに、同社はビジネス管理サービス、地域病院とその医師診療所向けの急性期医療EHRソリューションと関連サービス、患者エンゲージメントとテクノロジー・ソリューションも提供している。以前はComputer Programs and Systems, Inc.として知られていたが、2024年3月に社名をTruBridge, Inc.に変更した。トゥルーブリッジ・インクは1979年に設立され、アラバマ州モービルに本社を置いている。
TruBridge, Inc. 基礎のまとめ
| TBRG 基礎統計学 | |
|---|---|
| 時価総額 | US$384.20m |
| 収益（TTM） | US$4.26m |
| 売上高(TTM) | US$345.90m |
90.2x
PER（株価収益率1.1x
P/SレシオTBRG は割高か？
公正価値と評価分析を参照収益と収入
| TBRG 損益計算書（TTM） | |
|---|---|
| 収益 | US$345.90m |
| 売上原価 | US$161.81m |
| 売上総利益 | US$184.09m |
| その他の費用 | US$179.83m |
| 収益 | US$4.26m |
直近の収益報告
Mar 31, 2026
次回決算日
該当なし
| 一株当たり利益（EPS） | 0.29 |
| グロス・マージン | 53.22% |
| 純利益率 | 1.23% |
| 有利子負債／自己資本比率 | 91.7% |
TBRG の長期的なパフォーマンスは？
過去の実績と比較を見る企業分析と財務データの現状
| データ | 最終更新日（UTC時間） |
|---|---|
| 企業分析 | 2026/05/27 14:30 |
| 終値 | 2026/05/27 00:00 |
| 収益 | 2026/03/31 |
| 年間収益 | 2025/12/31 |
データソース
企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。
| パッケージ | データ | タイムフレーム | 米国ソース例 |
|---|---|---|---|
| 会社財務 | 10年 |
| |
| アナリストのコンセンサス予想 | +プラス3年 |
|
|
| 市場価格 | 30年 |
| |
| 所有権 | 10年 |
| |
| マネジメント | 10年 |
| |
| 主な進展 | 10年 |
|
* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。
特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。
分析モデルとスノーフレーク
本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。
シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。
業界およびセクターの指標
私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。
アナリスト筋
TruBridge, Inc. 5 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。23
| アナリスト | 機関 |
|---|---|
| Matthew Gillmor | Baird |
| Stephanie Davis | Barclays |
| Sean Dodge | BMO Capital Markets Equity Research |